FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.

Cui, Yan-Hong; Kim, Hyeonmi; Lee, Minyoung; Yi, Joo Mi; Kim, Rae-Kwon; Uddin, Nizam; Yoo, Ki-Chun; Kang, Jae Hyeok; Choi, Mi-Young; Cha, Hyuk-Jin; Kwon, Ok-Seon; Bae, In-Hwa; Kim, Min-Jung; Kaushik, Neha; Lee, Su-Jae

Cui, Yan-Hong; Kim, Hyeonmi; Lee, Minyoung; Yi, Joo Mi; Kim, Rae-Kwon; Uddin, Nizam; Yoo, Ki-Chun; Kang, Jae Hyeok; Choi, Mi-Young; Cha, Hyuk-Jin; Kwon, Ok-Seon; Bae, In-Hwa; Kim, Min-Jung; Kaushik, Neha; Lee, Su-Jae.

Afiliação

Cui YH; Department of Life Science, Research Institute for Natural Sciences, Hanyang University, Seoul, 04763, Republic of Korea.
Kim H; Department of Life Science, Research Institute for Natural Sciences, Hanyang University, Seoul, 04763, Republic of Korea.
Lee M; Division of Radiation Effect, Korea Institute of Radiological and Medical Sciences, Seoul, 01812, Korea.
Yi JM; Research Institute, Dongnam Institute of Radiological & Medical Sciences, Busan, South Korea.
Kim RK; Department of Life Science, Research Institute for Natural Sciences, Hanyang University, Seoul, 04763, Republic of Korea.
Uddin N; Department of Life Science, Research Institute for Natural Sciences, Hanyang University, Seoul, 04763, Republic of Korea.
Yoo KC; Department of Life Science, Research Institute for Natural Sciences, Hanyang University, Seoul, 04763, Republic of Korea.
Kang JH; Department of Life Science, Research Institute for Natural Sciences, Hanyang University, Seoul, 04763, Republic of Korea.
Choi MY; Department of Life Science, Research Institute for Natural Sciences, Hanyang University, Seoul, 04763, Republic of Korea.
Cha HJ; College of Pharmacy, Seoul National University, Seoul, Korea.
Kwon OS; College of Pharmacy, Seoul National University, Seoul, Korea.
Bae IH; Division of Basic Radiation Bioscience, Korea Institute of Radiological & Medical Sciences, Seoul, Korea.
Kim MJ; Laboratory of Radiation Exposure and Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Kaushik N; Department of Life Science, Research Institute for Natural Sciences, Hanyang University, Seoul, 04763, Republic of Korea. neha.bioplasma@gmail.com.
Lee SJ; Department of Life Science, Research Institute for Natural Sciences, Hanyang University, Seoul, 04763, Republic of Korea. sj0420@hanyang.ac.kr.

Oncogene ; 37(43): 5794-5809, 2018 10.

Article em En | MEDLINE | ID: mdl-29973690

Assuntos

Antígenos CD/metabolismo; Moléculas de Adesão Celular/metabolismo; Proteínas F-Box/metabolismo; MicroRNAs/genética; Proteínas de Neoplasias/metabolismo; Neoplasias de Mama Triplo Negativas/genética; Neoplasias de Mama Triplo Negativas/patologia; Ubiquitina-Proteína Ligases/metabolismo; Animais; Antígenos CD/genética; Antígenos de Neoplasias; Biomarcadores Tumorais/genética; Biomarcadores Tumorais/metabolismo; Moléculas de Adesão Celular/genética; Linhagem Celular Tumoral; Movimento Celular; Proteínas F-Box/genética; Feminino; Células HEK293; Humanos; Células MCF-7; Camundongos; Camundongos Endogâmicos BALB C; Camundongos Endogâmicos NOD; Camundongos SCID; Invasividade Neoplásica/genética; Proteínas de Neoplasias/genética; Transplante de Neoplasias; Prognóstico; Transplante Heterólogo; Neoplasias de Mama Triplo Negativas/mortalidade; Ubiquitina-Proteína Ligases/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos CD / Moléculas de Adesão Celular / MicroRNAs / Ubiquitina-Proteína Ligases / Proteínas F-Box / Neoplasias de Mama Triplo Negativas / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google